**Question:** Antibody seen in neonatal Lupus with conduction abnormalities in heart

**Core Concept:** Neonatal Lupus is a rare condition that occurs in infants born to mothers with systemic lupus erythematosus (SLE). It is caused by the passage of SLE-specific anti-Ro/SSA and anti-La/SSB antibodies from the mother to the fetus or newborn. These antibodies can lead to various clinical manifestations, including cardiac involvement. Conduction abnormalities are a common cardiac complication in neonatal lupus, characterized by defects in the conduction system, particularly affecting the atrioventricular (AV) node.

**Why the Correct Answer is Right:** The correct answer, **D**, is associated with neonatal lupus and its cardiac manifestations, particularly conduction abnormalities. The anti-Ro/SSA and anti-La/SSB antibodies present in neonatal lupus can cross the placenta and bind to cardiac cells, leading to inflammation and damage to the conduction system. This damage disrupts the normal electrical conduction in the heart, resulting in conduction abnormalities.

**Why Each Wrong Option is Incorrect:**

A. **Antibody seen in rheumatoid arthritis (RA)**: RA is an autoimmune disease that primarily affects synovial joints. It is caused by the production of autoantibodies, such as anti-cyclic citrullinated peptide (anti-CCP) antibodies, which do not correlate with neonatal lupus or its cardiac manifestations.

B. **Antibody associated with myasthenia gravis**: Myasthenia gravis is a neuromuscular disorder characterized by antibodies against nicotinic acetylcholine receptors (AChR) in the neuromuscular junction. This antibody is unrelated to neonatal lupus or its cardiac manifestations.

C. **Antibody linked to systemic sclerosis**: Systemic sclerosis is an autoimmune disease characterized by anti-centromere antibodies. It is unrelated to neonatal lupus or its cardiac manifestations.

**Clinical Pearl:** Neonatal lupus is a unique entity as it is caused by the passage of autoantibodies from the mother to the fetus or newborn. These antibodies can lead to various clinical features, including cutaneous manifestations, hepatosplenomegaly, and cardiac involvement. Cardiac involvement is the most severe form of neonatal lupus and can result in conduction abnormalities, heart block, and heart failure. Early recognition and management are crucial to prevent severe complications and improve the prognosis of affected infants and their mothers.